Literature DB >> 9112592

Subcortical type cognitive impairment in herpes zoster encephalitis.

L Hokkanen1, J Launes, E Poutiainen, L Valanne, O Salonen, J Sirén, M Iivanainen.   

Abstract

Nine immunocompetent patients with acute herpes zoster encephalitis (HZE) were studied with the help of neurological investigations. All patients were treated with acyclovir. Neuropsychological performance was compared with that of a group of 16 healthy controls. Computed tomography of the head showed infarct-like hypodense lesions in two patients, involving the internal capsule in one case and the temporoparietal cortex and white matter in another. Hypoperfusion shown by single photon emission computed tomography, mostly involving the frontal areas bilaterally, was seen in six of the seven patients examined. Hyperperfusion as seen in herpes simplex encephalitis was not encountered. One patient remained mildly demented, but all the other patients recovered relatively well. Neuropsychological examination after acyclovir treatment showed a decline in memory and speed of cognitive processes, without circumscribed neuropsychological deficits. Six of the nine patients showed behavioural disinhibition, and mood changes were also observed. Memory impairment in HZE was not as global or as severe as is described after encephalitis due to herpes simplex virus. In HZE both the brain perfusion pattern and the neuropsychological test profile showed features compatible with subcortical dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9112592     DOI: 10.1007/s004150050078

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  47 in total

Review 1.  ZOSTER ENCEPHALOMYELITIS.

Authors:  F C ROSE; E M BRETT; J BURSTON
Journal:  Arch Neurol       Date:  1964-08

2.  Effectiveness of intravenous acyclovir in immunocompetent patient with herpes zoster encephalitis.

Authors:  M K Whyte; P W Ind
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

3.  Population-based studies of varicella complications.

Authors:  H A Guess; D D Broughton; L J Melton; L T Kurland
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

4.  Herpes-zoster meningoencephalitis.

Authors:  F H Norris; R Leonards; P R Calanchini; C D Calder
Journal:  J Infect Dis       Date:  1970-10       Impact factor: 5.226

5.  Herpes zoster at the NIH: a 20 year experience.

Authors:  M H Mazur; R Dolin
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

6.  The limbic system and the localisation of herpes simplex encephalitis.

Authors:  A R Damasio; G W Van Hoesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

7.  An explanation for the localization of herpes simplex encephalitis?

Authors:  L E Davis; R T Johnson
Journal:  Ann Neurol       Date:  1979-01       Impact factor: 10.422

Review 8.  The problem of the frontal lobe: a reinterpretation.

Authors:  W J Nauta
Journal:  J Psychiatr Res       Date:  1971-08       Impact factor: 4.791

9.  SPECT, MRI and cognitive functions in multiple sclerosis.

Authors:  C Pozzilli; D Passafiume; S Bernardi; P Pantano; C Incoccia; S Bastianello; L Bozzao; G L Lenzi; C Fieschi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

10.  Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster.

Authors:  B Horten; R W Price; D Jimenez
Journal:  Ann Neurol       Date:  1981-03       Impact factor: 10.422

View more
  9 in total

1.  Dementia following herpes zoster encephalitis.

Authors:  Katherine J Bangen; Lisa Delano-Wood; Christina E Wierenga; Nikki H Stricker; John R Hesselink; Mark W Bondi
Journal:  Clin Neuropsychol       Date:  2010-05-24       Impact factor: 3.535

2.  Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study.

Authors:  Sigrun Alba Johannesdottir Schmidt; Katalin Veres; Henrik Toft Sørensen; Niels Obel; Victor W Henderson
Journal:  Neurology       Date:  2022-06-08       Impact factor: 11.800

Review 3.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

Review 4.  Cognitive outcome in acute sporadic encephalitis.

Authors:  L Hokkanen; J Launes
Journal:  Neuropsychol Rev       Date:  2000-09       Impact factor: 6.940

5.  Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study.

Authors:  Anna Grahn; Staffan Nilsson; Arto Nordlund; Thomas Lindén; Marie Studahl
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 6.682

6.  Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.

Authors:  Marie Eckerström; Staffan Nilsson; Henrik Zetterberg; Kaj Blennow; Anna Grahn
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

7.  Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort.

Authors:  Artitaya Lophatananon; Krisztina Mekli; Rachel Cant; Alistair Burns; Curtis Dobson; Ruth Itzhaki; Kenneth Muir
Journal:  BMJ Open       Date:  2021-10-08       Impact factor: 2.692

Review 8.  Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19.

Authors:  Quan She; Bo Chen; Wen Liu; Min Li; Weihong Zhao; Jianqing Wu
Journal:  Front Med (Lausanne)       Date:  2021-07-06

9.  An improved animal model for herpesvirus encephalitis in humans.

Authors:  Julia Sehl; Julia E Hölper; Barbara G Klupp; Christina Baumbach; Jens P Teifke; Thomas C Mettenleiter
Journal:  PLoS Pathog       Date:  2020-03-30       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.